{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:22:28Z","timestamp":1794471748433,"version":"4.9.1"},"reference-count":61,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":186,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156693"],"award-info":[{"award-number":["1156693"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021954","name":"Tour de Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000950","name":"Cancer Council South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022712","name":"Mark Hughes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001039","name":"Neurosurgical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin &amp; Trans Imm"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>CAR\u2010T cells are being investigated as a novel immunotherapy for glioblastoma, but clinical success has been limited. We recently described fibroblast activation protein (FAP) as an ideal target antigen for glioblastoma immunotherapy, with expression on both tumor cells and tumor blood vessels. However, CAR\u2010T cells targeting FAP have never been investigated as a therapy for glioblastoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We generated a novel FAP targeting CAR with CD3\u03b6 and CD28 signalling domains and tested the resulting CAR\u2010T cells for their lytic activity and cytokine secretion function\n                      <jats:italic>in\u00a0vitro<\/jats:italic>\n                      (using real\u2010time impedance, flow cytometry, imaging and bead\u2010based cytokine assays), and\n                      <jats:italic>in vivo<\/jats:italic>\n                      (using a xenograft mimicking the natural heterogeneity of human glioblastoma).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>FAP\u2010CAR\u2010T cells exhibited target specificity against model cell lines and potent cytotoxicity against patient\u2010derived glioma neural stem cells, even when only a subpopulation expressed FAP, indicating a bystander killing mechanism. Using co\u2010culture assays, we confirmed FAP\u2010CAR\u2010T cells mediate bystander killing of antigen\u2010negative tumor cells, but only after activation by FAP\u2010positive target cells. This bystander killing was at least partially mediated by soluble factors and amplified by IL\u20102 which activated the non\u2010transduced fraction of the CAR\u2010T product. Finally, a low dose of intravenously administered FAP\u2010CAR\u2010T cells controlled, without overt toxicity, the growth of subcutaneous tumors created using a mixture of antigen\u2010negative and antigen\u2010positive glioblastoma cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings advance FAP as a leading candidate for clinical CAR\u2010T therapy of glioblastoma and highlight under\u2010recognised antigen nonspecific mechanisms that may contribute meaningfully to the antitumor activity of CAR\u2010T cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cti2.1519","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:44:40Z","timestamp":1720179880000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Endogenous bystander killing mechanisms enhance the activity of novel FAP\u2010specific CAR\u2010T\u00a0cells against glioblastoma"],"prefix":"10.1002","volume":"13","author":[{"given":"Wenbo","family":"Yu","sequence":"first","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Cancer Clinical Trials Unit Royal Adelaide Hospital  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga TH","family":"Truong","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Cancer Clinical Trials Unit Royal Adelaide Hospital  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhi","family":"Polara","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Gargett","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Cancer Clinical Trials Unit Royal Adelaide Hospital  Adelaide SA Australia"},{"name":"Adelaide Medical School The University of Adelaide  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda N","family":"Tea","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M","family":"Pitson","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Adelaide Medical School The University of Adelaide  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaelia P","family":"Cockshell","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine S","family":"Bonder","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Adelaide Medical School The University of Adelaide  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-9666","authenticated-orcid":false,"given":"Lisa M","family":"Ebert","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Cancer Clinical Trials Unit Royal Adelaide Hospital  Adelaide SA Australia"},{"name":"Adelaide Medical School The University of Adelaide  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Brown","sequence":"additional","affiliation":[{"name":"Centre for Cancer Biology SA Pathology and University of South Australia  Adelaide SA Australia"},{"name":"Cancer Clinical Trials Unit Royal Adelaide Hospital  Adelaide SA Australia"},{"name":"Adelaide Medical School The University of Adelaide  Adelaide SA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov104"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.015"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1050"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1322"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0428"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa0984"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.10.002"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000260"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02875-1"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314390"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.9.3110"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5211"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.110"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0027"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3041"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.015"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-615"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-187"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1191"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01096-0"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130110"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1788"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz253.052"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401851"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0756"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400371"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/1547691X.2012.685527"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.2.608"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041522"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1301022110"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/ten.teb.2013.0285"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5274-9"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180444"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1364"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.03.014"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41277-z"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(96)80012-4"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830160826"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/319778a0"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0065"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061283"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0087"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0428"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.11.004"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5270.1947"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5355-7_14"},{"key":"e_1_2_11_51_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0316-1","article-title":"The activation of bystander CD8+ T\u00a0cells and their roles in viral infection","volume":"51","author":"Kim TS","year":"2019","journal-title":"Exp Mol Med"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1490019"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aap8112"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3168-5"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.011"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.5115\/acb.2015.48.1.25"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.046"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283412fd4"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0127"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.208"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2012.093"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02632-x"}],"container-title":["Clinical &amp; Translational Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cti2.1519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T22:07:47Z","timestamp":1721945267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cti2.1519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1002\/cti2.1519"],"URL":"https:\/\/doi.org\/10.1002\/cti2.1519","archive":["Portico"],"relation":{},"ISSN":["2050-0068","2050-0068"],"issn-type":[{"value":"2050-0068","type":"print"},{"value":"2050-0068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1519"}}